Why Abbott Stock Jumped Today
Yahoo Finance ·
Shares of Abbott Laboratories ( ABT +10.71% ) popped on Thursday after the healthcare products provider raised its full-year profit forecast. Abbott's sales rose 13% to $12.6 billion in the second quarter, boosted by its $21 billion acquisition of cancer screening leader Exact Sciences in March. The acquisition added more preventive products to Abbott's offerings, including Exact's market-leading noninvasive colorectal cancer screening test, Cologuard. Abbott's worldwide diagnostics sales surged 42.3% to $3.1 billion.
DYAX Investor Sentiment
Bullish (Long) 32% · Bearish (Short) 68%
420 participants
Related News
- 3 High-Yield Dividend Stocks to Buy and Hold
- Lucid Just Soared 29% After Calling Bankruptcy Rumors "Completely False." Here's What Its Balance Sheet Actually Shows.
- SpaceX sinks further below IPO price after Starship launch abort
- Asia markets bleed: Japan's Nikkei triggers broad tech retreat after U.S. chip slump
- Databricks targets $188B valuation in Coatue-led strategic funding round
- SpaceX, Alphabet, and SK Hynix Are Quietly Flashing a Bullish Signal Investors Should Not Ignore